Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative AKBA - Akebia Therapeutics, Inc.
100 M
LAST VALUE
-24.14%
2 YEAR CAGR
2.86%
5 YEAR CAGR
34.56%
10 YEAR CAGR